Video

Dr. Paul Discusses the Pulmonologist's Role in Managing Patients With Lung Cancer

Manju P. Paul, MD, assistant professor of medicine at Upstate University Hospital, discusses the pulmonologist’s role as part of the multidisciplinary approach in treating patients with non–small cell lung cancer (NSCLC).

Manju P. Paul, MD, assistant professor of medicine at Upstate University Hospital, discusses the pulmonologist’s role as part of the multidisciplinary approach in treating patients with non—small cell lung cancer (NSCLC).

Pulmonologists play a large role in diagnosing a patient with NSCLC, says Paul. As part of a multidisciplinary team, Paul and her colleagues meet every week to discuss and see patients with either a new diagnosis or an established diagnosis of lung cancer. Pulmonologists provide diagnostic techniques and staging techniques. For example, an endobronchial ultrasound enables pulmonologists to do a comprehensive mediastinal staging, which is crucial in treating patients. Additionally, interventional pulmonologists provide advanced bronchoscopic techniques to help palliate tumors, says Paul.

Rigid bronchoscopy, tumor ablation, and other techniques, such as laser, argon plasma, and cryotherapy, are used to help alleviate endobronchial obstruction, adds Paul. Pulmonologists are also are involved in treating patients with malignant pleural effusions by thoracentesis, PleurX catheters, and, if necessary, pleurodesis.

Related Videos
Alan Tan, MD, genitourinary oncology and melanoma specialist, Vanderbilt-Ingram Cancer Center; associate professor, medicine, Division of Hematology Oncology, Vanderbilt University Medical Center
Zosia Piotrowska, MD, MHS, instructor, Harvard Medical School; medical oncologist, Massachusetts General Hospital
Bartosz Chmielowski, MD
Raza Hoda, MD, FASCP
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD